Retractable Technologies

Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. It offers injection devices, blood collection devices, and infusion devices. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Celldex Therapeutics

Co-Diagnostics

Cardiff Oncology

Vaxart

These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.

These 5 Small-Cap Healthcare Stocks Gained the Most in 2020

Sales jumped 132% in the most recent quarter, as demand for the company's syringes have skyrocketed.

Why in the World Is Retractable Technologies Stock Up 566%?

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $10.3 million in the third quarter of 2020, compared to an operating income for the same period last year of $978 thousand and that income applicable to common shareholders was $11.0 million for the third quarter of 2020. During the third quarter, Retractable had an increase in net sales of approximately $15.5 million over the prior period, of which $12.9 million is attr

Retractable Technologies, Inc. Reports Increased Income and Sales for Third Quarter Of 2020

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $960 thousand in the second quarter of 2020, compared to an operating income for the same period last year of $329 thousand, and that income applicable to common shareholders was $3.6 million for the second quarter of 2020.

Retractable Technologies, Inc. Reports Increased Income and Sales for Second Quarter Of 2020

The company's been awarded a multimillion-dollar government COVID-19 contract to expand production of needles and syringes.

Here's Why Retractable Technologies Is Skyrocketing 22% Today

Retractable Technologies Inc. reported Q1 earnings highlighted by strong sales growth and firming profitability.

Retractable Technologies Inc.: Order For COVID-19 Vaccine Syringes Is A Game-Changer

Retractable Technologies (NYSE: RVP) shares are trading higher on Monday, after a report the company has won a government contract for $84 million.

Why Retractable Technologies Is Trading Higher Today

News for Retractable Technologies Stock (RVP)